Higher Fat Mass May Up Risk for Major Adverse CV Events in T2DM
However, increasing lean body mass does not appear to have a protective effect
More Aggressive Tx Needed for Familial Hypercholesterolemia
Even with care in specialty clinics, LDL cholesterol levels remain above targets for most patients
Women, Minorities Underrepresented in Cardiology Workforce
Women making gains in pediatric cardiology, but number of minorities remain low in adult, pediatric practice
Protected Health Info Breaches Compromise Sensitive Data
Most hospital data breaches include demographic or financial information that could be used for identity theft
SGLT2 Inhibitors Linked to Lower Risk for Heart Failure
Risk lower for HF, but not major CV events, compared with new users of DPP4 inhibitors
Cardiovascular Disease Risk Underestimated in Patients With Mental Illness
Severe mental illness should be included in cardiovascular assessment tools, authors say
Kidney Donation Linked to Increased Hypertension Risk
Mean eGFR increased for Caucasian and African-American kidney donors, plateaued after incident HTN
Linagliptin Noninferior for CV Risk in Early Type 2 Diabetes
Linagliptin compared with glimepiride for risk for major cardiovascular events in T2DM with elevated CV risk
CV Risk Lower With Metformin in T2DM + Reduced Kidney Function
Risk for major adverse cardiovascular events reduced with metformin compared with a sulfonylurea
Medical Students Not Ready to Provide Nutritional Care
Findings consistent regardless of country of training, year of medical education
